Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Papillomavirus Infections 4Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 3Pancreatic Neoplasms 3Neoplasms 3Multiple Myeloma 3Lymphoma, Follicular 3Triple Negative Breast Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Waldenstrom Macroglobulinemia 1Thymic aplasia 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pneumonia 1Osteosarcoma 1Obesity 1Neurofibromatosis 1 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Cyclosporins 2Cyclosporine 2Cyclophosphamide 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1plerixafor 1fosphenytoin 1fludarabine 1Thiotepa 1Therapeutics 1Tacrolimus 1Phlebotomy 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunologic Deficiency Syndromes × Blood Specimen Collection × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡